Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and futureChih-Hsin Yang
Future Oncology (London, England)|February 16, 2023
Afatinib for the treatment of non-small-cell lung cancer with unusual EGFR mutations: a plain language summaryJames Chih-Hsin Yang
Targeted Oncology|April 4, 2009
Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancerChia-Chi Lin, Chih-Hsin Yang
Drugs|December 24, 2010
Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutationsChia-Chi Lin, James Chih-Hsin Yang
Cancer Cell|February 13, 2024
Re-inventing a better wheel? Serplulimab for squamous cell lung cancerDerek De-Rui Huang, James Chih-Hsin Yang
Anticancer Research|August 5, 2003
Novobiocin sensitizes BCRP/MXR/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantroneChih-Hsin Yang, Yao-Chang Chen, Min-Liang Kuo
Discovery Medicine|July 1, 2010
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancerYu-Yun Shao, Chia-Chi Lin, Chih-Hsin Yang
Anticancer Research|March 31, 2021
CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung CancerSebastian Griesing, Bin-Chi Liao, James Chih-Hsin Yang
Therapeutic Advances in Medical Oncology|December 6, 2019
Second-line treatment of EGFR T790M-negative non-small cell lung cancer patientsBin-Chi Liao, Sebastian Griesing, James Chih-Hsin Yang
Annual Review of Medicine|January 28, 2020
Precision Management of Advanced Non-Small Cell Lung CancerChing-Yao Yang, James Chih-Hsin Yang, Pan-Chyr Yang
Pageof 33